CYSTM1 is a potential diagnostic and prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma - Zhang, Ning; Zhen, Junling; Kong, Xiangnan (Journal of Gastrointestinal Oncology, 2025)